MedPath

Detection of intratumoral heterogeneity of breast cancer by multiparametric imaging using 18F-FDG-PET/MRT

Not Applicable
Conditions
primary breasttumor
C50
Malignant neoplasm of breast
Registration Number
DRKS00013891
Lead Sponsor
niversitätsklinikum Tübingen, Radiologiesche Klinik, Interv. u. Diagnostische Radiologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
61
Inclusion Criteria

women, age =18 years,
proven primary breast carcinoma (by punch biopsy, =14G) (subtypes luminal A, B, and HER-/neu-pos. basal-like tumors)
tumor size =10 mm,
clinical indication for primary surgery,
contraception,
informed consent for clinical study,
informed consent for useage of biomaterial

Exclusion Criteria

clinical indication for neo-adjuvant therapy,
precnancy/breast feeding women,
contra-indication for MRT such as metallic implants, pacemaker etc., clip-marking of breast tumor,
contra-indication for MR-contrast agent Gadolinium,
claustrophobia, high sensitivity to temperatur sensitivity, high sensitivity to noise,
limited contractual capability,
exclusion criteria due to StrlSchV such as job-related radiation exposure >15mSv/a

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath